囊泡作为药物载体的研究进展

合集下载
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

囊泡作为药物载体的研究进展

赵 静,王仲妮*

(山东师范大学化学化工与材料科学学院,山东 济南 250014)

摘 要: 囊泡有较强的增溶能力,其双层膜具有较好的牢固性和稳定性,作为药物载体给药途径较广,载药稳定性、药物增溶量以及药物生物利用度较高。本文介绍了囊泡作为药物载体的研究现状,包括囊泡形成,膜结构选择和应用,以及囊泡在口服给药、局部给药和体内给药的应用。关键词:囊泡;表面活性剂;药物载体

中图分类号:R944.5 文献标识码:A 文章编号:1672-979X(2010)03-0129-04

收稿日期:2009-12-24

基金项目:山东省自然科学基金(Y2006B29),贵州省教育厅自然科学研究项目[黔教科(2007)016号]作者介绍:赵静(1985-),女,硕士研究生,从事胶体与界面化学研究

*

通讯作者:王仲妮,女,硕士生导师 E-mail: zhongniw@

Progress on V esicle as Drug Carrier

ZHAO Jing, W ANG Zhong-ni

(College of Chemistry, Chemical Engineering and Materials Science, Shandong Normal University, Jinan 250014,

China )

[4] Gould F A. Mitigation of surfactant erythrocyte toxicity by

egg phosphatidylcholine[J]. J Pharm Pharmacol , 2008, 52: 1203-1209.

[5] Buggins T R, Dickinson P A , Taylor G. The effects of

pharmaceutical excipients on drug disposition[J]. Adv Drug Deliv Rev , 2007, 59(15): 1482-1503.

[6] Filardo G, Blasi M D, Galia A, et al . Peracetylated β-cyclodextrin

as solubilizer of arylphosphines in supercritical carbon dioxide[J]. J Supercrit Fluid , 2006, 36(3): 173-181.

[7] Górnicki A. The hemolysis kinetics of psoriatic red blood cells[J].

Blood Cell Mol Dis , 2008, 41(2): 154-157.

[8] Pierigè F, Sera fi ni S, Rossi L, et al . Cell-based drug delivery[J].

Adv Drug Deliv Rev , 2008, 60: 286-295.

[9] Savi ć S, Weber C, Savi ć M M, et al . Natural surfactant-based

topical vehicles for two model drugs: Influence of different lipophilic excipients on in vitro/in vivo skin performance[J]. Int J Pharm , 2009, 381(2): 220-230.

[10] Bandyopadhyay P, Neeta N S. Evidence for vesicle formation

from 1:1 nonionic surfactant span 60 and fatty alcohol mixtures in aqueous ethanol: Potential delivery vehicle composition[J]. Colloid Surf B: Biointerface , 2007, 58(2): 305-308.

[11] Ohnishi M, Sagitani H. The effect of nonionic surfactant structure

on hemolysis[J]. J Am Oil Chem Soc , 1993, 70(7): 679-684.[12] Prete P S C, Gomes K, Malheiros S V P. Solubilization of

human erythrocyte membranes by non-ionic surfactants of the polyoxyethylene alkyl ethers series[J]. Biophys Chem , 2002, 97: 45-54.

[13] Galembeck E, Meirelles N C. Effects of polyoxyethylene chain

length on erythrocyte hemolysis induced by poly[oxyethylene (n ) nonylphenol] non-ionic surfactants[J]. Chem-Biol Interact , 1998, 113: 91-103.

[14] 孙岩, 陈怡,等. 烷基糖苷与生物膜的相互作用及其溶血活性

[J]. 表面活性剂工业,1998, 2: 3-6.

[15] Sanchez L, Vinardell M P. Potential irritation of lysine derivative

surfactants by hemolysis and HaCaT cell viability[J]. Toxicol Lett , 2006, 161: 53-60.

[16] Vives M A, Vinardell M P. Erythrocyte hemolysis and shape

changes induced by new lysine-derivate surfactants[J]. Chem-Biol Interact , 1999, 118: 1-18.

[17] Vinardell M P. Characteristics of interaction between amphiphiles

and membranes[J]. Trends Comp Biochem Physiol , 1996, 2: 73-82.

[18] Groot R D, Rabone K L, et al . Mesoscopic simulation of cell

membrane damage, morphology change and rupture by nonionic surfactants[J]. Biophys J , 2001, 81: 725-736.

[19] Shalel S, Streichman S, Marmur A. The mechanism of hemolysis

by surfactants:effect of solution composition[J]. J Colloid Inter Sci , 2002, 252: 66-76.

[20] Lichtenberg D, Opatowski E, Koslov M, et al . Phase boundaries

in mixtures of membrane-forming amphiphiles and micelle-forming amphiphiles[J]. BBA-Biomembranes , 2000, 1508: 1-19.[21] Sánchez L, Martínez V, Infante M R, et al . Hemolysis and

antihemolysis induced by amino acid-based surfactants[J]. Toxicol Lett , 2007, 169(2): 177-184.

相关文档
最新文档